Literature DB >> 7905890

Nosocomial catheter-associated bacteriuria: a clinical trial comparing two closed urinary drainage systems.

J C Wille1, A Blussé van Oud Alblas, E A Thewessen.   

Abstract

We compared the time of onset and incidence of nosocomial bacteriuria between two different closed urinary drainage systems: a simple closed drainage system containing an antireflux valve ('Urias A-4') and a complex closed drainage system ('Curity Infection Control System') incorporating: (1) a preconnected, coated catheter, (2) a tamper discouraging seal at the catheter-drainage tubing junction, (3) a drip chamber, (4) an antireflux valve, (5) a hydrophobic drainage bag vent and (6) a povidone-iodine releasing cartridge in line with the outlet tube of the urine collection bag. 181 non-bacteriuric patients, requiring catheter drainage for more than 48 h, were assigned by chance to either of the two systems. Bacteriological monitoring of bladder urines of the enrolled patients was performed every 24 h by establishing viable counts and identification of all microorganisms. No differences in the onset and incidence of nosocomial bacteriuria between the two urine drainage system groups were noted. We conclude that additional complex features aimed at preventing intraluminal spread of bacteria did not reduce the risk of urinary tract infection, compared to a simple closed urinary drainage system.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 7905890     DOI: 10.1016/0195-6701(93)90037-z

Source DB:  PubMed          Journal:  J Hosp Infect        ISSN: 0195-6701            Impact factor:   3.926


  2 in total

1.  Randomised study of sterile versus non-sterile urethral catheterisation.

Authors:  E A Carapeti; S M Andrews; P G Bentley
Journal:  Ann R Coll Surg Engl       Date:  1996-01       Impact factor: 1.891

2.  Comparison of effectiveness of two urinary drainage systems in intensive care unit: a prospective, randomized clinical trial.

Authors:  Marc Leone; Franck Garnier; François Antonini; Marie-Christine Bimar; Jacques Albanèse; Claude Martin
Journal:  Intensive Care Med       Date:  2003-02-08       Impact factor: 17.440

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.